|Day Low/High||36.35 / 36.70|
|52 Wk Low/High||33.97 / 46.47|
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Wednesday's trending stocks from the floor of the New York Stock Exchange.
For Pfizer, China is third largest market and a growing area of concern.
We believe the company has double-digit total return potential at its current price.
The Dow tumbled Wednesday, losing ground for the first session in five, after the U.S. threatened additional tariffs on $200 billion worth of China-made goods.
Pfizer reorganization could pave way for the company to spin off businesses.
Pfizer announced plans Wednesday to reorganize into three units.
The stock faces a lot of headwinds on a day when markets are trying to surmount trade-war woes.
The changes will take effect at the start of 2019.
The bets are coming off one table and going to another amid the tariff news, much to the consternation of the sideliners.
U.S. stock futures fall sharply on Wednesday, after the White House publishes a list of $200 billion worth of China-made goods it says will be hit with fresh tariffs; Twenty-First Century Fox increases its bid to buy Britain's Sky; Pfizer to 'defer' raising drug prices following talks with Donald Trump.
Pfizer bowed to pressure from President Donald Trump late Tuesday by agreeing to temporarily rollback a planned price increase following Tweets suggesting the group "should be ashamed".
Here are the business stories you must know as U.S. stock futures fall sharply.
Pfizer Inc. (NYSE:PFE) today announced it will organize the company into three businesses: a science-based Innovative Medicines business which will now include biosimilars and a new hospital business unit for anti-infectives and sterile injectables; an...
Following an extensive discussion with President Trump today, Pfizer's Chairman and CEO Ian Read announced that it will defer the company's price increases that were effective on July 1 to give the president an opportunity to work on his blueprint to...
President Trump criticized Pfizer and others in a tweet on July 9, saying they hiked prices 'for no reason.'
The seemingly terrific rationales for strength in these economically sensitive sectors seem glib until the bigger global economic issues get resolved.
While President Trump pledged last month that pharma companies would decide to voluntarily aggress to 'massive' drops in drug prices, clearly nobody told Pfizer.
Why study charts? Because they're like footprints at the scene of the crime, clues to what the big money managers are likely thinking, Jim Cramer says.
Pfizer Inc. (NYSE:PFE) announced today that the European Commission (EC) has approved XELJANZ ® (tofacitinib citrate) 5 mg twice daily (BID) in combination with methotrexate (MTX) for the treatment of active psoriatic arthritis (PsA) in adult patients who...
The board of directors of Pfizer Inc. today declared a 34-cent third-quarter 2018 dividend on the company's common stock, payable September 4, 2018, to shareholders of record at the close of business on August 3, 2018.
Pfizer Inc. (NYSE:PFE) today announced that the U.
Pfizer today announced overall survival (OS) results from the Phase 3 PALOMA-3 trial, which evaluated IBRANCE ® (palbociclib) in combination with fulvestrant compared to placebo plus fulvestrant in women with hormone receptor-positive (HR+), human...
The Duchenne Muscular Dystrophy specialist announces early results that show a gene-based treatment for the debilitating disease may be just two years away.
Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.
While the CREATES ACT passed out of committee in the Senate, Senator Orrin Hatch, who helped pave the way for generic drugs in the U.S,,voted against the measure.
Don't count on it. The fundamentals paint two very different pictures, Cramer says.
Pfizer Inc. announced today it will extend its donation of the antibiotic Zithromax® (azithromycin) to the International Trachoma Initiative through 2025, building on the company's 20-years of work to help eliminate the world's leading infectious cause of...
A healthcare bill supported on both sides of the aisle was held up until Sen. Chuck Grassley talked with pharma companies.
Pfizer Inc. (NYSE:PFE) announced today that the U.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.